RVTY Revvity Inc.

P/E 53.11
Forward P/E 21.1
Price/Sales 4.246
Beta 1.091
Div Yield 0.0025%
Market Cap --

Company Analysis

Latest News

Revvity Attracts Massive Wellington Investment, Following Earnings Beat

Revvity Attracts Massive Wellington Investment, Following Earnings Beat

Wellington Management Group LLP increased its stake in life sciences and diagnostics firm Revvity Inc. by 10,653.8% during the second quarter. The firm...

🟢 Revvity is trading 4% up today on healthcare-sector strength

Revvity is trading 4.01% up now at $131.66, primarily as healthcare-sector strength improves medical-technology sentiment. - Healthcare is up 1.37%, with...

Revvity shares climb 5%, as institutional backing reaches 86%

Revvity shares climb 5%, as institutional backing reaches 86%

Revvity Inc. shares rose 5.0% to $119.45 on August 19, 2026. A valuation analysis by GuruFocus suggests the stock is currently overvalued relative to...

🟢 Revvity is trading 4.04% up today amid healthcare sector rotation

Revvity is trading at $124.28, up +4.04%, amid healthcare sector rotation. - Healthcare led broader sector rotation, rising 3.23% during regular trading. - No...

🟢 Revvity is trading 6.1% up today amid sector rotation into healthcare

Revvity is trading 6.1% up at $120.82, with sector rotation into healthcare the strongest current explanation. - It is outperforming the recent August 18,...

🔴 Revvity is trading 4.04% down today on profit-taking after strong earnings

Revvity is trading at $110.60 (-4.04%) as investors lock in gains following a significant post-earnings rally. • The company reported Q2 revenue of $730...

Revvity's second quarter revenue of $730M and adj. EPS of $1.41 beat estimates, leading to a raised full-year outlook.

Revvity's second quarter revenue of $730M and adj. EPS of $1.41 beat estimates, leading to a raised full-year outlook.

Revvity reported second quarter 2026 results that exceeded analyst expectations, driven by strong performance in its Diagnostics segment. The company posted...

Revvity Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026

Analysts expect Revvity to report Q2 2026 revenue of approximately $703.2 million and adjusted EPS of $1.23, with the stock currently trading near $112.52...

🟢 Revvity is trading 4.7% up today as it recovers from recent weakness

Revvity is trading at $111.42 (4.7%) up today, bouncing back from yesterday’s decline despite a lack of fresh, stock-specific news or major announcements...

Revvity Surges 8% on Rosy Outlook and Lower Debt — But Can a Leaner Balance Sheet Justify a Premium Valuation?

Revvity Surges 8% on Rosy Outlook and Lower Debt — But Can a Leaner Balance Sheet Justify a Premium Valuation?

Shares of Revvity (RVTY) vaulted 8.1% to $120.11 on July 14 after S&P Global Ratings upgraded the company's outlook, citing improving leverage and strong cash...

🟢 Revvity is trading 8.1% up today after outlook upgrade and solid cash flow expectations

Revvity is trading 8.1% up at $120.11 following an outlook upgrade and solid cash flow expectations highlighted by S&P Global. • The move builds on momentum...

🟢 RVTY is trading 4.2% up today following strong Q1 earnings and positive analyst sentiment

RVTY is trading 4.2% higher at $118.53 in pre-market, extending a strong recent uptrend after solid Q1 2026 results and gradually improving analyst...

Revvity integrates Anthropic’s Claude, accelerating scientific discovery through AI

Revvity integrates Anthropic’s Claude, accelerating scientific discovery through AI

Revvity, Inc. announced its Revvity Signals Software business is integrating with Anthropic’s AI model, Claude. This collaboration adds Revvity to Anthropic’s...